Loading...
OTCMSAUHY
Market cap20bUSD
Dec 20, Last price  
12.78USD
1D
1.91%
1Q
-12.47%
Name

Straumann Holding AG

Chart & Performance

D1W1MN
OTCM:SAUHY chart
P/E
7.44
P/S
0.76
EPS
1.54
Div Yield, %
6.25%
Shrs. gr., 5y
0.10%
Rev. gr., 5y
12.08%
Revenues
2.41b
+3.92%
420,296,000509,553,000599,204,000713,654,000778,708,000736,361,000737,648,000693,581,000686,253,000679,922,000710,270,000798,600,000917,516,0001,112,102,0001,363,560,0001,596,225,0001,425,851,0002,021,903,0002,320,785,0002,411,819,000
Net income
246m
-43.40%
99,948,000127,863,000141,725,000175,866,0008,163,000146,373,000131,084,00070,952,00036,438,000101,201,000157,825,00070,679,000229,600,000272,917,000272,770,000306,473,00091,282,000396,079,000434,789,000246,072,000
CFO
504m
+21.39%
144,201,000144,491,000174,581,000223,153,000198,758,000245,142,000175,841,000140,216,000114,560,000151,490,000146,160,000185,598,000184,743,000217,290,000277,099,000378,478,000376,594,000560,303,000415,155,000503,950,000
Dividend
Apr 25, 20240.044 USD/sh
Earnings
Feb 25, 2025

Profile

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
IPO date
Jun 01, 1998
Employees
10,543
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,411,819
3.92%
2,320,785
14.78%
2,021,903
41.80%
Cost of revenue
2,006,779
1,894,891
1,581,395
Unusual Expense (Income)
NOPBT
405,040
425,894
440,508
NOPBT Margin
16.79%
18.35%
21.79%
Operating Taxes
98,811
63,655
78,099
Tax Rate
24.40%
14.95%
17.73%
NOPAT
306,229
362,239
362,409
Net income
246,072
-43.40%
434,789
9.77%
396,079
333.91%
Dividends
(127,445)
(107,432)
(91,381)
Dividend yield
Proceeds from repurchase of equity
(18,311)
2,094
4,078
BB yield
Debt
Debt current
28,943
306,608
25,846
Long-term debt
595,819
616,674
907,451
Deferred revenue
70,160
122,136
Other long-term liabilities
326,283
29,642
71,063
Net debt
32,471
18,987
(67,628)
Cash flow
Cash from operating activities
503,950
415,155
560,303
CAPEX
(153,770)
(195,434)
(120,970)
Cash from investing activities
(349,332)
(434,659)
(175,216)
Cash from financing activities
(424,398)
(154,309)
(131,240)
FCF
109,028
157,400
388,552
Balance
Cash
413,537
697,113
881,498
Long term investments
178,754
207,182
119,427
Excess cash
471,700
788,256
899,830
Stockholders' equity
1,838,606
1,761,318
1,433,751
Invested Capital
2,105,542
1,750,688
1,400,780
ROIC
15.88%
22.99%
25.65%
ROCE
15.36%
16.43%
18.89%
EV
Common stock shares outstanding
159,603
159,572
159,592
Price
Market cap
EV
EBITDA
535,273
588,599
543,714
EV/EBITDA
Interest
17,946
17,189
17,037
Interest/NOPBT
4.43%
4.04%
3.87%